To identify genomic regions specifically methylated or unmethylated in the initial biopsy specimens of responders (patients with pCR), genome-wide DNA methylation analysis was conducted using samples in the screening set (Table 1), namely: i) 10 samples from responders (pCR samples), ii) 11 samples from non-responders (non-pCR samples), iii) normal breast epithelial cell lines, and iv) an HER2-positive breast cancer cell line. This evidence concerns the gene ERBB2 and breast carcinoma.